Peptides

Tesamorelin (Egrifta) Explained: An FDA-Approved GHRH Analog for HIV Lipodystrophy

Tesamorelin has one thing no other GHRH analog peptide can claim: an FDA approval. That approval is real, the Phase 3 trial data behind it are solid, and the mechanism is well understood. But the indication is narrow — HIV-associated lipodystrophy, specifically the excess visceral fat that accumulates in people on long-term antiretroviral therapy — […]

Tesamorelin (Egrifta) Explained: An FDA-Approved GHRH Analog for HIV Lipodystrophy Read More »

Leuprolide (Lupron) Explained: GnRH Agonist for Cancer, Endometriosis, and CPP

If you or someone you care for has been prescribed Lupron — or if you have seen leuprolide mentioned in the context of prostate cancer, endometriosis, or early puberty in a child — you have probably wondered how a single drug ends up treating three conditions that appear to have nothing in common. The honest

Leuprolide (Lupron) Explained: GnRH Agonist for Cancer, Endometriosis, and CPP Read More »

Insulin Explained: The Original Peptide Drug and How It Still Defines the Class

Every peptide article eventually circles back to the same molecule. When researchers argue that peptide drugs can be both precise and safe, they point to a century of clinical data. When skeptics ask whether synthetic chains of amino acids can actually replace a biological function, the answer is yes — and it has been yes

Insulin Explained: The Original Peptide Drug and How It Still Defines the Class Read More »

Wegovy vs. Zepbound: Which FDA-Approved Weight-Loss Peptide Works Better?

Bottom line Zepbound (tirzepatide) demonstrated a greater average weight reduction of 20.2% compared to Wegovy (semaglutide) at 13.7% over 72 weeks in a head-to-head trial. This 6.5 percentage-point difference was both statistically and clinically significant. Comparison Factors: Beyond average weight loss, consider side-effect tolerance, drug mechanism, insurance coverage, and prescriber comfort. Regulatory Status: Both Wegovy

Wegovy vs. Zepbound: Which FDA-Approved Weight-Loss Peptide Works Better? Read More »

Ozempic vs. Mounjaro: Side-by-Side on Mechanism, Outcomes, and Side Effects

Everyone seems to have an opinion about which drug is better. Endocrinologists debate trial endpoints. Reddit threads run for hundreds of comments comparing injections and nausea episodes. Pharmacies can barely keep either in stock. If you have been prescribed one of these medications — or are trying to understand a conversation your doctor is having

Ozempic vs. Mounjaro: Side-by-Side on Mechanism, Outcomes, and Side Effects Read More »

CJC-1295 vs. Ipamorelin: Comparison and Why They’re Often Stacked

If you are researching CJC-1295 and ipamorelin, you have probably read that stacking these two peptides is the "gold standard" for growth hormone optimization. That claim is circulating in forums, fitness podcasts, and grey-market vendor copy with a confidence the published literature does not support. So before this article explains the pharmacology, here is the

CJC-1295 vs. Ipamorelin: Comparison and Why They’re Often Stacked Read More »

GHRP-2 vs. GHRP-6: Honest Comparison of Two Grey-Market GHRPs

If you spend any time in fitness or longevity forums, you will eventually encounter people comparing GHRP-2 and GHRP-6 as if choosing between them is a straightforward personal preference — like picking between two protein powder flavors. It is not that simple, and the framing is worth pushing back on before you read anything else.

GHRP-2 vs. GHRP-6: Honest Comparison of Two Grey-Market GHRPs Read More »

Semax vs. Selank: Russian Peptides Compared on the Evidence

If you have spent any time in nootropic communities, you have almost certainly seen Semax and Selank mentioned together, usually by someone who describes them as "Russian government peptides" with an air of forbidden wisdom. That framing is not entirely wrong. Both compounds were developed in the Soviet Union, both are approved drugs in Russia

Semax vs. Selank: Russian Peptides Compared on the Evidence Read More »

MK-677 (Ibutamoren) Explained: It’s Not a Peptide, and Why That Matters

MK-677 shows up in nearly every "peptide" bodybuilding forum thread, stacked alongside CJC-1295 and ipamorelin, praised for boosting growth hormone without injections. The trouble is that calling it a peptide is factually wrong — and the distinction is not pedantic. MK-677 is a small synthetic molecule, the closest thing the bodybuilding world has to an

MK-677 (Ibutamoren) Explained: It’s Not a Peptide, and Why That Matters Read More »

Bremelanotide (Vyleesi) Deep Dive: How the FDA-Approved Libido Peptide Works

Bremelanotide is one of only a handful of FDA-approved peptide drugs that a licensed physician can actually prescribe in the United States today — and almost everything sold online as "PT-141" is a compounded version that is not the same product. That distinction matters enormously, because it is the difference between a therapy tested in

Bremelanotide (Vyleesi) Deep Dive: How the FDA-Approved Libido Peptide Works Read More »

Scroll to Top